This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: Wolfgang Baether: Innovator in Protozoal Disease Treatment
Introduction
Wolfgang Baether is a notable inventor based in Dreieichenhain, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target protozoal diseases. His work has implications for improving treatment options in this area.
Latest Patents
Wolfgang Baether holds a patent for Bis-(1-alkyl-5-nitro-imidazolyl-2-alkyl)-compounds. This patent describes the compounds and a process for their manufacture. The compounds are recognized for their activity against protozoal diseases, showcasing Baether's innovative approach to addressing health challenges.
Career Highlights
Baether is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to focus on research and development in medicinal compounds, contributing to advancements in healthcare.
Collaborations
Wolfgang Baether has collaborated with Erhardt Winkelmann, enhancing the research efforts in their field. Their partnership has likely fostered innovative ideas and solutions in the development of new treatments.
Conclusion
Wolfgang Baether's contributions to the field of medicinal chemistry, particularly through his patent on Bis-(1-alkyl-5-nitro-imidazolyl-2-alkyl)-compounds, highlight his role as an innovator in the fight against protozoal diseases. His work continues to influence the pharmaceutical industry and improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile